Short communication
Impact of the presence of oxytetracycline residues in milk destined for
the elaboration of dairy products: The specific case of mature goat
cheese
P. Quintanilla
a
, M. Cornacchini
b
, M.I. Hernando
c
, M.P. Molina
a
, I. Escriche
d, *
a
Institute for Animal Science and Technology, Universitat Polit ecnica de Val encia, Camino de Vera, s/n, 46022, Valencia, Spain
b
National Institute of Industrial Technology, San Martín, B1650WAB, Buenos Aires, Argentina
c
Food Microstructure and Chemistry Research Group, Department of Food Technology, Universitat Polit ecnica de Val encia, Camino de Vera, s/n, 46022,
Valencia, Spain
d
Institute of Food Engineering for Development, Department of Food Technology, Universitat Polit ecnica de Val encia, Camino de Vera, s/n, 46022, Valencia,
Spain
article info
Article history:
Received 3 January 2019
Received in revised form
24 October 2019
Accepted 24 October 2019
Available online 6 November 2019
abstract
This study evaluated instrumental parameters (chemical composition, colour, texture and microstruc-
ture) and sensory characteristics of goat cheese (60-day maturation) made with milk spiked with
oxytetracycline at different levels: 0, 50, 100 (maximum residue limit; MRL) and 200 mg kg
À1
. Addi-
tionally, the influence of this antibiotic on the cheese making process was evaluated and proved that the
presence of oxytetracycline in milk significantly delayed the total time of manufacture in proportion to
its concentration. The presence of this antibiotic in raw milk, even at a concentration of up to double the
MRL, affected some of the parameters only slightly (pH, FFA concentration, luminosity, springiness and
chewiness) in the ripened cheeses, without being perceptible by the sensory panel. Consequently, cheese
made from milk containing oxytetracycline would go unnoticed by consumers.
© 2019 Elsevier Ltd. All rights reserved.
1. Introduction
Oxytetracycline is the most commonly used tetracycline for
food-producing species in veterinary treatment of diseases (EMA,
2018). Improper use of antibiotics, especially with regard to the
withdrawal period, could be a cause for the presence of antibiotic
residues in milk and, therefore, in dairy products. To ensure food
safety, maximum residue limits (MRLs) for different pharmaco-
logically active substances in foods of animal origin, such as milk,
have been established (European Commission, 2010); however, for
some dairy products, no limits have been set for antibiotics.
In industrialised countries, antibiotic control is routine in the
dairy industry, provided that specific screening methods are used
for tetracyclines, but their use is rather rare in goat milk (Beltr an,
Althaus, Molina, Berruga, & Molina, 2015); thus, the presence of
residues does not pose a great risk to the consumer in such coun-
tries. However, most goat milk is produced in underdeveloped
countries, where there are either no control systems in place or
they are poorly implemented, making it more likely that milk
containing antibiotic residues could be used in cheese-making.
Indeed, antibiotic residues have been found in marketed dairy
products such as cheese (Tona & Olusola, 2014). Recently, in an
investigation of fresh goat cheese, made with milk containing a
concentration equivalent to MRL, Quintanilla, Dom enech, Escriche,
Beltr an, and Molina (2019b) found that oxytetracycline was
retained to a large extent (37% rate of the initial concentration in
milk).
The presence of antibiotic residues in milk destined for the
production of dairy products could have adverse effects on human
health (Berruga, Molina, Althaus, & Molina, 2016) and also have
negative technological effects (Berruga, Molina, Noves, Rom an, &
Molina, 2007; Cabizza et al., 2017). Expanding the knowledge of
the impact of the presence of antibiotics on the manufacturing
process, and the physicochemical characteristics of dairy products
is of great importance for the industry, the consumer and health
administrations. Therefore, the present study focuses on mature
cheese made from goat milk spiked at different levels (MRL and/or
above and below) with oxytetracycline by evaluating its impact on
* Corresponding author. Tel.: þ34 963877007x73661.
E-mail address: iescrich@tal.upv.es (I. Escriche).
Contents lists available at ScienceDirect
International Dairy Journal
journal homepage: www.elsevier.com/locate/idairyj
https://doi.org/10.1016/j.idairyj.2019.104595
0958-6946/© 2019 Elsevier Ltd. All rights reserved.
International Dairy Journal 101 (2020) 104595